ADAPTIMMUNE THERAPEUTICS PLC Debt Securities, Available-for-sale, Realized Gain
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Debt Securities, Available-for-sale, Realized Gain of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGain · last filed 2025-03-24
- ADAPTIMMUNE THERAPEUTICS PLC debt securities, available-for-sale, realized gain for the quarter ending 2019-12-31 was $0.00.
- ADAPTIMMUNE THERAPEUTICS PLC debt securities, available-for-sale, realized gain for the quarter ending 2019-09-30 was $0.00.
- ADAPTIMMUNE THERAPEUTICS PLC debt securities, available-for-sale, realized gain for the quarter ending 2019-06-30 was $13.00K.
- ADAPTIMMUNE THERAPEUTICS PLC debt securities, available-for-sale, realized gain for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- ADAPTIMMUNE THERAPEUTICS PLC debt securities, available-for-sale, realized gain for fiscal 2023 was $198.00M.
- ADAPTIMMUNE THERAPEUTICS PLC debt securities, available-for-sale, realized gain for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- ADAPTIMMUNE THERAPEUTICS PLC debt securities, available-for-sale, realized gain for fiscal 2021 was $6.00K, a 93.26% decline from fiscal 2020.
| Period end | Debt Securities, Available-for-sale, Realized Gain 3 month | Debt Securities, Available-for-sale, Realized Gain 6 month | Debt Securities, Available-for-sale, Realized Gain 9 month | Debt Securities, Available-for-sale, Realized Gain 12 month | Debt Securities, Available-for-sale, Realized Gain 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-24 | ||||
| 2023-12-31 | $198.00M 10-K · filed 2025-03-24 | $198.00K 10-K · filed 2024-03-06 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-24 | ||||
| 2021-12-31 | $6.00K 10-K · filed 2024-03-06 | ||||
| 2020-12-31 | $89.00K 10-K · filed 2023-03-06 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $0.00 derived: sum of 2 quarters · filed 2022-03-14 | $13.00K derived: sum of 3 quarters · filed 2022-03-14 | $13.00K 10-K · filed 2022-03-14 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $13.00K derived: sum of 2 quarters · filed 2019-11-06 | $13.00K 10-Q · filed 2019-11-06 | ||
| 2019-06-30 | $13.00K 10-Q · filed 2019-08-01 | $13.00K 10-Q · filed 2019-08-01 |